DIBc nano metal-organic framework improves biochemical and pathological parameters of experimental chronic kidney disease.

Fakharzadeh, Saideh; Argani, Hassan; Torbati, Peyman Mohammadi; Dadashzadeh, Simin; Kalanaky, Somayeh; Nazaran, Mohammad Hassan; Basiri, Abbas.

Afiliação

Fakharzadeh S; Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
Argani H; Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Torbati PM; Department of Pathology, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Dadashzadeh S; Department of Pharmaceutics and Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kalanaky S; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
Nazaran MH; Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. Electronic address: mnazaran@nanochelatingtechnology.com.
Basiri A; Urology and Nephrology Research Center, Shahid Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: basiri@unrc.ir.

J Trace Elem Med Biol ; 61: 126547, 2020 May 11.

Article em En | MEDLINE | ID: mdl-32460199